Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study.


Journal

Diabetes & metabolism
ISSN: 1878-1780
Titre abrégé: Diabetes Metab
Pays: France
ID NLM: 9607599

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 06 11 2020
revised: 20 04 2021
accepted: 29 04 2021
pubmed: 24 5 2021
medline: 23 3 2022
entrez: 23 5 2021
Statut: ppublish

Résumé

To analyze the association of objective and subjective sleep measures with HbA1c and insulin sensitivity in the general population. Using a cross-sectional design, data from 1028 participants in the ORISCAV-LUX-2 study from the general population in Luxembourg were analyzed. Objective sleep measures were assessed using accelerometers whereas subjective measures were assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Sleep measures were defined as predictors, while HbA1c and quantitative insulin sensitivity check index (QUICKI) scores were considered outcomes. Linear and spline regression models were fitted by progressively adjusting for demographic and lifestyle variables in the total sample population as well as by stratified analyses using gender, obesity status, depressive symptoms and diabetes status. In fully adjusted models, total and deep sleep durations were associated with lower HbA1c (mmol/mol) levels, whereas sleep coefficients of variation (%) and poor sleep efficiency, as measured by PSQI scores (units), were associated with higher HbA1c levels. In stratified models, such associations were observed mainly in men, and in subjects who had depressive symptoms, were overweight and no diabetes. In addition, total sleep, deep sleep, coefficients of variation and poor sleep efficiency as measured by PSQI revealed non-linear associations. Similarly, greater insulin sensitivity was associated with longer total sleep time and with PSQI-6 (use of sleep medication). Associations were more frequently observed between sleep characteristics and glycaemic control with the use of objective sleep measures. Also, such associations varied within subgroups of the population. Our results highlight the relevance of measuring sleep patterns as key factors in the prevention of diabetes.

Identifiants

pubmed: 34023494
pii: S1262-3636(21)00046-X
doi: 10.1016/j.diabet.2021.101263
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101263

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

G A Aguayo (GA)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg. Electronic address: gloria.aguayo@lih.lu.

J Pastore (J)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

A Backes (A)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

S Stranges (S)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg; Department of Epidemiology and Biostatistics and Family Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.

D R Witte (DR)

Department of Public Health, Aarhus University, Aarhus, Denmark; Steno Diabetes Center Aarhus, Aarhus, Denmark.

N J Diederich (NJ)

Department of Neurosciences, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.

A Alkerwi (A)

Directorate of Health, Luxembourg-Hamm, Luxembourg.

L Huiart (L)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

M Ruiz-Castell (M)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

L Malisoux (L)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

G Fagherazzi (G)

Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH